TRDA
Entrada Therapeutics, Inc. · Healthcare
President and CEO Dipal Doshi sold $219K of Entrada Therapeutics, Inc.
Sold$219,119
$15.02Price
14,590Shares
−8%Stake
What TRDA did after the filing
- The stock from Thu, Dec 29 close, $14.12
- +13.5%
- S&P 500, same days
- +7.7%
Measured over 30 trading days, to the Feb 13 close.
Traded Tue, Dec 27. Filed Thu, Dec 29, 11:51 AM ET, during the session. Returns use the Dec 29 close and the Feb 13 close. Not investment advice.